{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:45:03Z","timestamp":1787010303357,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:p>\n                    To evaluate the correlation between p16 expression and clinical outcomes in patients with primary vaginal cancer treated with definitive radiotherapy. P16 immunohistochemical was performed on 25 patient samples and recorded from pathology reports in 7 patients. P53 immunohistochemical was performed on 3 p16-negative samples. Baseline characteristics were compared using the Fisher exact test. Outcomes were compared using log-rank tests, and cox proportional hazards models. Survival and recurrence analysis was performed with the Kaplan-Meier method and cumulative incidence estimates. P16 expression was positive in 29 patients and negative in 3 patients. Two of the p16-negative tumors showed positive expression of p53. The median overall survival, progression-free survival and 2-yr cumulative incidence of recurrence were 66\u2009mo [95% confidence interval (CI), 31\u201396], 34\u2009mo (95% CI, 21\u201386), and 19% (95% CI, 7%\u201334%), respectively. P16-positive tumors had higher median overall survival and progression-free survival compared with p16-negative tumors (82 vs. 31\u2009mo,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.02 and 35 vs 16\u2009mo,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.04, respectively). The 2-yr cumulative incidence of recurrence was 14% for p16-positive tumors compared with 67% for p16-negative tumors (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.07). On univariable analysis, p16-negative status, age older than 65, and advanced stage were associated with inferior overall survival. P16 negativity is an independent predictor of inferior overall survival. P16-positive vaginal cancers have a better prognosis and decreased incidence of recurrence compared with p16-negative tumors. These prognostic findings associated with p16-negative vaginal cancers will need to be confirmed in larger patient cohorts.\n                  <\/jats:p>","DOI":"10.1097\/pgp.0000000000000568","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T01:59:01Z","timestamp":1543975141000},"page":"588-596","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic Significance of P16 Expression and P53 Expression in Primary Vaginal Cancer"],"prefix":"10.1097","volume":"38","author":[{"given":"Chika R.","family":"Nwachukwu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy P.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Von Eyben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Giaretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny L.","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Hiniker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Kapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann K.","family":"Folkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00256406-200509150-00001","article-title":"Vaginal cancer","volume":"25","author":"Creasman","year":"2005","journal-title":"Postgrad Obstet Gynecol"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0020-7292(06)60029-5","article-title":"Carcinoma of the vagina","volume":"95","author":"Beller","year":"2006","journal-title":"Int J Gynecol Obstet"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1002\/ijc.23446","article-title":"Risk factors for invasive squamous cell carcinoma of the vulva and vagina\u2014population-based case\u2013control study in Denmark","volume":"122","author":"Madsen","year":"2008","journal-title":"Int J Cancer"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/gyno.2001.6502","article-title":"A population-based study of squamous cell vaginal cancer: HPV and cofactors","volume":"84","author":"Daling","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00292-011-1476-5","article-title":"HPV-assoziierte Ver\u00e4nderungen an Vulva und Vagina","volume":"32","author":"Horn","year":"2011","journal-title":"Pathologe"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1048-891x.2004.014310.x","article-title":"Primary carcinoma of the vagina: factors influencing the age at diagnosis. The Radiumhemmet series 1956-96","volume":"14","author":"Hellman","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1365-2559.2010.03727.x","article-title":"Primary squamous cell carcinoma of the vagina: human papillomavirus detection, p16INK4A overexpression and clinicopathological correlations","volume":"57","author":"Fuste","year":"2010","journal-title":"Histopathology"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/1097-0142(197503)35:3<787::AID-CNCR2820350334>3.0.CO;2-K","article-title":"The pathologic behavior of primary vaginal carcinoma and its relationship to cervical cancer","volume":"35","author":"Murad","year":"1975","journal-title":"Cancer"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/01.pas.0000213251.82940.bf","article-title":"p16 Overexpression Identifies HPV-positive vulvar squamous cell carcinomas","volume":"30","author":"Santos","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/IGC.0b013e31821bc615","article-title":"The prognostic role of human papillomavirus in patients with vaginal cancer","volume":"21","author":"Brunner","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ygyno.2011.12.449","article-title":"Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina","volume":"125","author":"Alonso","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/bjc.2014.32","article-title":"Human papillomavirus, p16INK4A and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina","volume":"110","author":"Hellman","year":"2014","journal-title":"Br J Cancer"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1097\/PAS.0b013e3181e84652","article-title":"p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status","volume":"34","author":"Lewis","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/ijc.22355","article-title":"Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer","volume":"120","author":"Reimers","year":"2007","journal-title":"Int J Cancer"},{"key":"R17-20230824","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1002\/cncr.25033","article-title":"Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience","volume":"116","author":"Singhi","year":"2010","journal-title":"Cancer"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2013.52.3464","article-title":"Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal","volume":"32","author":"Serup-Hansen","year":"2014","journal-title":"J Clin Oncol"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1038\/sj.onc.1209275","article-title":"Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus","volume":"25","author":"Smeets","year":"2006","journal-title":"Oncogene"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/jnci\/djh183","article-title":"Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus","volume":"96","author":"Braakhuis","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"key":"R22-20230824","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1158\/1078-0432.CCR-07-1402","article-title":"Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck","volume":"14","author":"Westra","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R23-20230824","first-page":"1655","article-title":"Carcinoma of the vulva: HPV and p53 mutations","volume":"9","author":"Lee","year":"1994","journal-title":"Oncogene"},{"key":"R24-20230824","first-page":"1739","article-title":"p53 Expression in vulvar carcinoma, vulvar intraepithelial neoplasia, squamous cell hyperplasia and lichen sclerosus","volume":"25","author":"Hantschmann","year":"2005","journal-title":"Anticancer Res"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/bjc.2015.20","article-title":"HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53","volume":"112","author":"Meulendijks","year":"2015","journal-title":"Br J Cancer"},{"key":"R26-20230824","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"JNCI J Natl Cancer Inst"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1200\/JCO.2008.20.2853","article-title":"Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck","volume":"27","author":"Lassen","year":"2009","journal-title":"J Clin Oncol"},{"key":"R28-20230824","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ygyno.2013.08.012","article-title":"Primary squamous cell carcinoma of the vagina: prognostic factors, treatment patterns, and outcomes","volume":"131","author":"Hiniker","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R29-20230824","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1309\/AJCPMG0XIF7PEISO","article-title":"Improved survival in p16-positive vaginal cancers across all tumor stages but no correlation with MIB-1","volume":"142","author":"Feldbaum","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"R30-20230824","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/MOO.0000000000000341","article-title":"Is p16 an adequate surrogate for human papillomavirus status determination?","volume":"25","author":"Jouhi","year":"2017","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"R31-20230824","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"R32-20230824","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00280-014-2582-x","article-title":"Prognostic value of human papillomavirus in anal squamous cell carcinoma","volume":"74","author":"Ravenda","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"R33-20230824","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijrobp.2011.11.032","article-title":"Prognostic significance of p16 expression in advanced cervical cancer treated with definitive radiotherapy","volume":"84","author":"Schwarz","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"R34-20230824","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2016.05.019","article-title":"Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma of the vulva treated with radiotherapy","volume":"142","author":"Lee","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R35-20230824","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0002-9378(91)90086-7","article-title":"Vulvar squamous cell carcinoma and papilloma viruses: two separate entities?","volume":"165","author":"Andersen","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"R36-20230824","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/modpathol.2010.192","article-title":"Differentiated vulvar intraepithelial neoplasia is often found in lesions, previously diagnosed as lichen sclerosus, which have progressed to vulvar squamous cell carcinoma","volume":"24","author":"Van De Nieuwenhof","year":"2010","journal-title":"Mod Pathol"},{"key":"R37-20230824","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/01.pgp.0000130108.03231.89","article-title":"Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva","volume":"23","author":"Santos","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R38-20230824","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jnci\/djn025","article-title":"Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers","volume":"100","author":"Gillison","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R39-20230824","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3802\/jgo.2016.27.e17","article-title":"Definitive treatment of primary vaginal cancer with radiotherapy: multi-institutional retrospective study of the Korean Radiation Oncology Group (KROG 12-09)","volume":"2","author":"Chang","year":"2016","journal-title":"J Gynecol Oncol"},{"key":"R40-20230824","doi-asserted-by":"crossref","first-page":"661","DOI":"10.15585\/mmwr.mm6526a1","article-title":"Human papillomavirus\u2013associated cancers\u2014United States, 2008\u20132012","volume":"65","author":"Viens","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T21:00:19Z","timestamp":1720818019000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000568","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}